Unity Biotechnology

Q: Where is Unity Biotechnology located?

Unity Biotechnology's headquarters are located at 285 E Grand Ave, South San Francisco, California, 94080, United States

Q: What is Unity Biotechnology's phone number?

Unity Biotechnology's phone number is (650) 416-1192

Q: What is Unity Biotechnology's stock symbol?

Unity Biotechnology's stock symbol is UBX

Q: What is Unity Biotechnology's official website?

Unity Biotechnology's official website is www.unitybiotechnology.com

Q: What is Unity Biotechnology's Revenue?

Unity Biotechnology's revenue is <$5 Million

Q: What is Unity Biotechnology's SIC code?

Unity Biotechnology's SIC: 87,873

Q: What is Unity Biotechnology's NAICS code?

Unity Biotechnology's NAICS: 54,541

Q: How many employees does Unity Biotechnology have?

Unity Biotechnology has <25 employees

Q: What industry does Unity Biotechnology belong to?

Unity Biotechnology is in the industry of: Business Services General , Business Services

Q: What is Unity Biotechnology competition?

Unity Biotechnology top competitors include: Fulcrum Therapeutics , TorreyPines Therapeutics , Otonomy , Synlogic

Business Services · California, United States · <25 Employees

View Company Info for Free

About

Headquarters

285 E Grand Ave, South San Francisco, Californi...

Phone Number

(650) 416-1192

Website

www.unitybiotechnology.com

Revenue

<$5 Million

Stock Symbol

UBX

Industry

Business Services General

Business Services

Most Recent Scoops

Jan 6 2025

New Hire

Federico Grossi has joined the company as Chief Medical Officer. Previously, Grossi was Chief Medical Officer for Apellis Pharmaceuticals.

Aug 15 2024

Left Company

Unity Biotechnology has announced that Sharon Klier, Chief Development Officer & Head of Ophthalmology, has left the organization to join Oculis Holding as Chief Development Officer.

See all scoops

Highlights

$373M

Total Funding Amount

$80M

Most Recent Funding Amount

Number of Funding Rounds

View details

Who is Unity Biotechnology

UNITY Biotechnology is developing therapeutics that reshape healthspan by preventing, halting, or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related afflictions such as osteoarthritis, eye diseases and pulmonary diseases.Explore more

Is this data correct?

View contact profiles from Unity Biotechnology

Popular Searchesunity biotechnology IncUnity BiotechnologyUnitybiotechnologyUnited Biotechnologies IncUnitybio CorpSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: UBXShow more

Unity Biotechnology Org Chart

Phone

Lynne Sullivan

Chief Financial Officer

Phone

Federico Grossi

Chief Medical Officer

Phone

Is Unity Biotechnology your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Funding: Get notified immidiatlly once Unity Biotechnology has new funding data

Unity Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic

Congratulate Masked Content for being promoted to Masked Content at Unity Biotechnology

Check out if Unity Biotechnology is spiking on competitors!

Check if Unity Biotechnology has recently received funding, and reach out quickly before it becomes old news!

Earning: See what the market has to say on Unity Biotechnology recently announced quarterly report

Click to see if Unity Biotechnology had a recent Job posting/layoffs

Website visits: Recent activity has been detected on your website

Product Launch: Get notified when Unity Biotechnology launches new products

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Recommended Actions

Introduce yourself to Masked Content, who has shown a strong intent to purchase lately

Find 2 more new buyers

Compare Similar Companies to Unity Biotechnology

Compare insights from companies similar to Unity Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Unity Biotechnology

<$5M

Fulcrum Therapeutics

$81.6M

AC Immune

$18.4M

Magenta Therapeutics

$15.9M

TorreyPines Therapeutics

$13.4M

Synlogic

<$5M

Otonomy

<$5M

View Email Formats for Unity Biotechnology

Unity Biotechnology financials insights

Gather financial insights about Unity Biotechnology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

Graph showing recent funding, most recent acquisition, and main investor information for Unity Biotechnology.

See All Financials Insights

Unity Biotechnology Employee Growth Rate

Graph showing projected employee growth data for Unity Biotechnology

View Unity Biotechnology’s full employee growth data

Percentage of growth

1st year Mask

2nd year Mask

Unity Biotechnology Tech Stack

A closer look at the technologies used by Unity Biotechnology

PHP

See more technologies

Most Recent Scoops

Jan 6 2025

New Hire

Federico Grossi has joined the company as Chief Medical Officer. Previously, Grossi was Chief Medical Officer for Apellis Pharmaceuticals.

Executive Moves, New Hire

Aug 15 2024

Left Company

Unity Biotechnology has announced that Sharon Klier, Chief Development Officer & Head of Ophthalmology, has left the organization to join Oculis Holding as Chief Development Officer.

Executive Moves, Left Company

Jul 22 2024

New Hire

Executive Move

Alicia Tozier has been named Chief Strategy Officer. Previously, Tozier served as Senior VP for Outlook Therapeutics.

Executive Moves, New Hire

May 20 2024

Earnings

Unity Biotechnology has recently announced 2024 Q1 report with the following insight: UBX faces uncertainty accessing financial markets given conditions like high interest rates. Without financing, development timelines could be delayed or development could cease.

Financial Planning

May 20 2024

Earnings

Asset Management

See more scoops

Unity Biotechnology News & Media

UNITY Biotechnology Reports Granting of New Employment Inducement Award
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that on January 6, 2025, the Compensation Committee of the Board of Directors (the “Board”) granted a stock-based award to a new employee, Federico Grossi, UNITY’s Chief Medical Officer, covering options to purchase 150,000 shares of UNITY common stock. The stock-based award w
Jan 7, 2025
www.globenewswire.com
UNITY Biotech Appoints SYFOVRE Developer Dr. Grossi as CMO Ahead of Key DME Trial ...
UNITY Biotechnology strengthens leadership with Federico Grossi, former Apellis CMO who led SYFOVRE approval, as company approaches Phase 2b ASPIRE trial readout for UBX1325.
Jan 6, 2025
www.stocktitan.net
UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today strengthened the executive leadership team with the appointment of Federico Grossi, M.D., Ph.D., as chief medical officer. Dr. Grossi brings a wealth of experience in clinical development and regulatory strategy in ophthalmology and other indications, most recently having led the development of SYFOVR
Jan 6, 2025
www.globenewswire.com
UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates
UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates
Nov 4, 2024
www.globenewswire.com
UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024
UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024
Sep 24, 2024
www.globenewswire.com

Top Companies in United States

Frequently Asked Questions Regarding Unity Biotechnology

Where is Unity Biotechnology located?

Unity Biotechnology's headquarters are located at 285 E Grand Ave, South San Francisco, California, 94080, United States

What is Unity Biotechnology's phone number?

Unity Biotechnology's phone number is (650) 416-1192

What is Unity Biotechnology's stock symbol?

Unity Biotechnology's stock symbol is UBX

What is Unity Biotechnology's official website?

Unity Biotechnology's official website is www.unitybiotechnology.com

What is Unity Biotechnology's Revenue?

Unity Biotechnology's revenue is <$5 Million

What is Unity Biotechnology's SIC code?

Unity Biotechnology's SIC: 87,873

What is Unity Biotechnology's NAICS code?

Unity Biotechnology's NAICS: 54,541

How many employees does Unity Biotechnology have?

Unity Biotechnology has <25 employees

What industry does Unity Biotechnology belong to?

Unity Biotechnology is in the industry of: Business Services General, Business Services

What is Unity Biotechnology competition?

Unity Biotechnology top competitors include: Fulcrum Therapeutics, TorreyPines Therapeutics, Otonomy, Synlogic

What technology does Unity Biotechnology use?

Some of the popular technologies that Unity Biotechnology uses are: WordPress.org, Drupal, reCAPTCHA, PHP

Who is the CFO of Unity Biotechnology?

Unity Biotechnology's CFO is Lynne Sullivan

How do I contact Unity Biotechnology?

Unity Biotechnology contact info: Phone number: (650) 416-1192 Website: www.unitybiotechnology.com

What does Unity Biotechnology do?

What are Unity Biotechnology social media links?

Unity Biotechnology Linkedin page Unity Biotechnology Twitter page Unity Biotechnology Facebook page

How much funding has Unity Biotechnology raised to date?

Unity Biotechnology has raised $373 Million in 5 funding rounds

When was the last funding round for Unity Biotechnology?

Unity Biotechnology closed its last funding round on Aug 04, 2020 with the amount of $80 Million

Who invested in Unity Biotechnology?

Unity Biotechnology has 28 investors including Fidelity Management & Research Company, WuXi AppTec, Bezos Expeditions and Undisclosed.

Is Unity Biotechnology a public company?

Yes, Unity Biotechnology is a public company and is traded under the symbol UBX

See more information about Unity Biotechnology

Unity Biotechnology Latest Hires and Their Positions

Unity Biotechnology is expanding and recently hired new employees. Here are the latest additions to the team.

Alicia Tozier

Chief Strategy Officer

Joined Jul 1, 2024

Phone

Ted Chan

Intellectual Property Counsel & Consultant

Joined Jun 1, 2024

Phone

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.